Clik here to view.
TearLab osmolarity test in UK DED prevalence study
In collaboration with the UK’s National Health Service (NHS), four ophthalmologists are beginning a 1,000-patient multi-center study to assess the overall prevalence of dry eye disease (DED), using the...
View ArticleClik here to view.
TearLab reports interim results of DED prevalence study in UK
TearLab (NASDAQ:TEAR; TSX:TLB) has reported interim results of a multi-center dry eye disease (DED) prevalence study being carried out in the UK at four National Health Service (NHS) hospitals. The...
View ArticleClik here to view.
GeneNews gets promising early results from lung cancer study
GeneNews (TSX:GEN) has received encouraging early results from the largest randomized trial ever conducted for the early detection of lung cancer using EarlyCDT-Lung, an autoantibody biomarker blood...
View ArticleClik here to view.
In conversation with Geoffrey Hamilton-Fairley
Mr. Hamilton-Fairley As CEO of closely-held Oncimmune, an early cancer diagnostic company in Britain, Geoffrey Hamilton-Fairley has had a personal commitment to cancer detection. His father was the...
View Article
